Antibiotics and bacterial infections

Acute bacterial skin and skin structure infections

US landscape assessment of acute bacterial skin and skin structure infections (ABSSSI) and osteomyelitis
Local market adaptations of economic models in ABSSSI

Pre-budget impact analysis and economic advice for personalized medicine: approaches to diagnose and control clostridium difficile infections

Value communication support in acute otitis media associated with respiratory syncytial virus (RSV)
Diary of a caregiver validation for ear infection using the standard methodology
Training and manuscripts on the acute otitis media caregiver diary
Quality of life impact of otitis media and associated productivity loss in Malaysia and South Korea

Cost-effectiveness model of a treatment for bacterial infections
Cost-effectiveness analysis model for Portugal on a treatment for bacterial infections
Cost-effectiveness analysis of a treatment of intra-abdominal infections in the USA
Assessment of the commercial and economic value for the development of new diagnostic tests for respiratory infections
HEOR team capabilities audit and training plan in infectious diseases
Literature review and development of a suite of dossiers in anti-infectives (antibacterial resistance)
Literature review of antibiotic resistance
Global value dossier, slide deck and FAQs on antibiotic resistance in gram-negative infections
Update to an anti-infectives dossier in gram negative bacterial infections
Literature review on the clinical outcome assessment (COA) landscape of bacterial respiratory infections
COA landscape review and literature review in a vaccine for respiratory bacterial infections
Systematic literature review on competitor real word evidence in antibiotic resistance
Demonstrating the value of antibiotic resistance testing software
Development of a manuscript and consulting on economic evaluations alongside a clinical trial in intra-abdominal infections
Manuscript on a real-world evidence literature review in Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP)
Pharmacoeconomic and PRO design and analysis for an immunoglobulin product
Analysis in an EU study in primary immunodeficiency

Manuscripts on the health economics of a pneumococcal vaccine
Manuscript on cost-effectiveness analysis in pneumococcal disease
Manuscripts on a vaccine for pneumococcal disease
Payer value deck for pneumococcal disease
Payer value deck for a pneumococcal disease vaccine
Payer communications on pneumococcal disease
Payer communications on a vaccine for pneumococcal disease
Payer material development for vaccines in pneumococcal disease
Responses to payer questions update on a pneumococcal disease vaccine
Update to a one-page value proposition on a pneumococcal disease vaccine
ev@luate platform for vaccine franchises in pneumococcal disease
Payer resources (payer value deck, FAQs and one-pager) for a pneumococcal vaccine
Payer value deck in adult pneumococcal disease (pneumococcal conjugate vaccination)

Manuscript on a real-world evidence literature review in Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP)
Manuscript and e-v@luate platform in respiratory outcomes for HABP and VABP

Development of an interactive model for skin and nasal antiseptic for infection prevention, allowing users to tailor settings to stakeholders’ specific circumstances at a regional or local level or within hospital departments
Scientific communication of a budget impact model for prevention of surgical skin infections